These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 462584)

  • 41. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancy.
    Vaughn CB; Chapman JL; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Brady PR
    Oncology; 1981; 38(3):129-33. PubMed ID: 7010257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep).
    Kemeny N; Yagoda A; Braun D; Golbey R
    Cancer; 1980 Mar; 45(5):876-81. PubMed ID: 7260839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
    Windschitl HE; Krook JE; Everson LK; Cullinan SA; Scott M
    Cancer Treat Rep; 1982 Dec; 66(12):2093-4. PubMed ID: 7139652
    [No Abstract]   [Full Text] [Related]  

  • 44. Chemotherapy of large intestinal carcinoma. Current results and future prospects.
    Schein PS; Kisner D; MacDonald JS
    Cancer; 1975 Dec; 36(6 Suppl):2418-20. PubMed ID: 764960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA; Richardson RL; Shulman SF; Oldham RK
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract]   [Full Text] [Related]  

  • 47. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
    Giles GR; Hall R; Brennan TG; Worthy TS
    Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
    [No Abstract]   [Full Text] [Related]  

  • 48. Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma.
    Sordillo PP; Magill GB
    Am J Clin Oncol; 1982 Jun; 5(3):277-9. PubMed ID: 6282110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.
    Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK
    Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response of metastatic cloacogenic carcinoma to treatment with semustine.
    Zimm S; Wampler GL
    Cancer; 1981 Dec; 48(12):2575-6. PubMed ID: 7306917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical management of advanced gastrointestinal cancer.
    Moertel CG
    Cancer; 1975 Aug; 36(2):675-82. PubMed ID: 168961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Walter Hubert lecture Chemotherapy of upper gastrointestinal carcinoma.
    Moertel CG
    Br J Cancer; 1976 Sep; 34(3):325-34. PubMed ID: 184809
    [No Abstract]   [Full Text] [Related]  

  • 53. An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.
    Lacave A; Wils J; Bleiberg H; Diaz-Rubio E; Duez N; Dalesio O
    J Clin Oncol; 1987 Sep; 5(9):1387-93. PubMed ID: 3305795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 55. The nitrosoureas--thoughts for the future.
    Carter SK; Wasserman TH
    Cancer Treat Rep; 1976 Jun; 60(6):807-11. PubMed ID: 954014
    [No Abstract]   [Full Text] [Related]  

  • 56. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced colorectal cancer.
    Vaughn CB; Chapman J; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Enochs K; Groshko G; Rocchio R
    Am J Clin Oncol; 1986 Jun; 9(3):196-9. PubMed ID: 3088974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Treat Rep; 1976 Jun; 60(6):729-32. PubMed ID: 954012
    [No Abstract]   [Full Text] [Related]  

  • 58. [Chemotherapy of gastrointestinal tumors (review of the literature)].
    Mayr AC
    Onkologie; 1978 Dec; 1(6):248-56. PubMed ID: 83561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.
    Lokich JJ; Skarin AT
    Cancer Chemother Rep; 1972 Oct; 56(5):653-7. PubMed ID: 4569058
    [No Abstract]   [Full Text] [Related]  

  • 60. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
    Roth A; Kolarić K
    Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.